Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
USE OUR INTELLIGENCE

Fatigue, Headache Among Top Lingering Symptoms Months After Covid
VIRUSES & VACCINES
August 8, 2022

Fatigue, Headache Among Top Lingering Symptoms Months After Covid

Fatigue and headache were the most common symptoms reported by individuals an average of more…

USE OUR INTELLIGENCE August 8, 2022
Down on Vitamin D? It Could Be the Cause of Chronic Inflammation
DISEASES
August 8, 2022

Down on Vitamin D? It Could Be the Cause of Chronic Inflammation

Inflammation is an essential part of the body’s healing process. But when it persists, it can…

USE OUR INTELLIGENCE August 8, 2022
Early Diagnosis of Lung Cancer Among Younger Vs. Older Adults: Widening Disparities in the Era of Lung Cancer Screening
DISEASES
August 8, 2022

Early Diagnosis of Lung Cancer Among Younger Vs. Older Adults: Widening Disparities in the Era of Lung Cancer Screening

Younger patients with lung cancer are significantly more likely than older patients to be diagnosed…

USE OUR INTELLIGENCE August 8, 2022
Study Finds Full-Occupancy, In-Person Teaching Did Not Lead to SARS-CoV-2 In-Class Transmission at Boston University
POLICY & LAW
August 6, 2022

Study Finds Full-Occupancy, In-Person Teaching Did Not Lead to SARS-CoV-2 In-Class Transmission at Boston University

Is there evidence of in-class transmission of SARS-CoV-2 on a university campus that has mandated…

USE OUR INTELLIGENCE August 6, 2022
Proposed Device Could Detect Allergens, Fire Accelerants, Chemical Markers of Disease
RESEARCH
August 6, 2022

Proposed Device Could Detect Allergens, Fire Accelerants, Chemical Markers of Disease

A University of Texas at Arlington electrical engineering researcher is creating a portable, wearable device…

USE OUR INTELLIGENCE August 6, 2022
New York National Guard Covid Response Is Now the Largest Domestic Mobilization in U.S. History
PUBLIC HEALTH
August 6, 2022

New York National Guard Covid Response Is Now the Largest Domestic Mobilization in U.S. History

Beginning in early March 2020, military forces in the State of New York, comprising the…

USE OUR INTELLIGENCE August 6, 2022
Extending the Shelf Life of Vaccines
VIRUSES & VACCINES
August 6, 2022

Extending the Shelf Life of Vaccines

Nearly half of all vaccines go to waste. This is due to the logistical obstacles…

USE OUR INTELLIGENCE August 6, 2022
Reshaping How Doctors and Researchers Share Phenotypic Information: First GA4GH Standard Published by ISO
RESEARCH
August 6, 2022

Reshaping How Doctors and Researchers Share Phenotypic Information: First GA4GH Standard Published by ISO

The International Organization for Standardization (ISO) has published Phenopackets, the first clear computational way to…

USE OUR INTELLIGENCE August 6, 2022
https://globalhealthnewswire.com/28vcasalagos
TECHNOLOGY
August 6, 2022

https://globalhealthnewswire.com/28vcasalagos

Implantable devices that release insulin into the body hold promise as an alternative way to…

USE OUR INTELLIGENCE August 6, 2022
Johns Hopkins Medicine-Led Consortium to Receive Up to 0 Million to Fight TB Globally
VIRUSES & VACCINES
August 5, 2022

Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally

To address the global burden of tuberculosis (TB), one of humankind’s oldest scourges, an international…

USE OUR INTELLIGENCE August 5, 2022
Older Posts Newer Posts
Latest Posts
  • Check for Copycat Bias in Medical AI
    TECHNOLOGY
    Check for Copycat Bias in Medical AI
    USE OUR INTELLIGENCE September 2, 2026
  • Brain Cancer: Immunotherapy First, Surgery Afterwards
    NEUROLOGY & MENTAL HEALTH, PHARMA & CLINICAL TRIALS
    Brain Cancer: Immunotherapy First, Surgery Afterwards
    USE OUR INTELLIGENCE September 2, 2026
  • Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    TECHNOLOGY
    Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    USE OUR INTELLIGENCE September 2, 2026
  • FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    PHARMA & CLINICAL TRIALS
    FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    USE OUR INTELLIGENCE September 2, 2026
  • Not All ‘Magic’ Mushrooms Are the Same
    PUBLIC HEALTH
    Not All ‘Magic’ Mushrooms Are the Same
    USE OUR INTELLIGENCE September 2, 2026
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

Global Health News Wire
  • HOME
  • GHNW Notes
  • PERMISSIONS AND POLICIES
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

I would like to receive critical industry news to my inbox.

Our site uses cookies. Learn more about our use of cookies: Cookie Policy

ACCEPT